Selecta Biosciences
SELB
$0.88
Share price
-8.00%
Change (1 day)
-36.60%
Change (1 year)
Categories
Operating Margin for Selecta Biosciences (SELB)
Operating Margin as of May 2024 (TTM): -15.15%
According to Selecta Biosciences's latest financial reports and stock price the company's current Operating Margin is -15.15%. At the end of 2021 the company had an Operating Margin of -11.43%.
Operating Margin history for Selecta Biosciences from 2015 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -11.43% | -97.25% |
| 2020 | -414.99% | -49.94% |
| 2019 | -828.97% | -88.54% |
| 2018 | -7,235.44% | -77.07% |
| 2017 | -31,556.04% | 6944.12% |
| 2016 | -447.98% | 6.97% |
| 2015 | -418.80% | -1.15% |
| 2014 | -423.68% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.